Aignostics Partners with the Pancreatic Cancer Action Network to Advance Pancreatic Cancer Research
Collaboration will apply Aignostics’ AI-technology to PanCAN’s multimodal pancreatic cancer dataset, with results made broadly accessible to both academic and life sciences researchers. LOS ANGELES and BERLIN and NEW YORK, June 9,
